Cargando…
Immune Checkpoint Blockade in Gynecologic Cancers: State of Affairs
SIMPLE SUMMARY: Most endometrial cancer patients are diagnosed at an early stage, receive standard treatment, and survive well. Ovarian cancer has no specific symptoms and usually escapes diagnosis until the patient has advanced disease. This disease results in the highest number of deaths of gyneco...
Autores principales: | Drakes, Maureen L., Czerlanis, Cheryl M., Stiff, Patrick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695253/ https://www.ncbi.nlm.nih.gov/pubmed/33182298 http://dx.doi.org/10.3390/cancers12113301 |
Ejemplares similares
-
Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
por: Drakes, Maureen L., et al.
Publicado: (2018) -
Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy
por: Drakes, Maureen L, et al.
Publicado: (2014) -
Immune checkpoint blockades in gynecological cancers: A review of clinical trials
por: Peng, Hongling, et al.
Publicado: (2022) -
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
por: Liu, Ying L., et al.
Publicado: (2018) -
Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)